Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study Meeting Abstract


Authors: Beer, T. M.; Armstrong, A. J.; Sternberg, C. N.; Higano, C. S.; Iversen, P.; Loriot, Y.; Rathkopf, D. E.; Bhattacharya, S.; Carles, J.; de Bono, J. S.; Evans, C. P.; Joshua, A. M.; Kim, C. S.; Kimura, G.; Mainwaring, P. N.; Mansbach, H. H.; Miller, K.; Noonberg, S. B.; Venner, P. M.; Tombal, B.
Abstract Title: Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study
Meeting Title: 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 4 Suppl.
Meeting Dates: 2014 Jan 30-Feb 1
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-02-01
Language: English
ACCESSION: WOS:000335318100002
PROVIDER: wos
DOI: 10.1200/jco.2014.32.4_suppl.lba1
Notes: Meeting Abstract: LBA1 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf